Company Profile
Intelligent Bio Solutions Stock Price, News & Analysis
- Ticker:
- INBS
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
1.99 USD (+11.17%)
Close
Last updated: August 6, 2026
6.08M USD
Market cap
Why the stock is moving
The latest company update was “Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission”. INBS changed 1.10% and closed at $1.79 on Aug 5, 2026, indicating a relatively limited closing-price reaction to this fda / regulatory update.
Company overview
Business overview
Intelligent Bio Solutions is a diagnostics company focused on rapid biosensor testing and point-of-care identification. Its business centers on using sensor technology to improve screening and clinical workflows.
Geographic Base and Sector Classification
Intelligent Bio Solutions is headquartered in the United States and listed on NASDAQ. It sits in diagnostics and medical devices rather than biotechnology therapeutics.
Business Model Characteristics
The company depends on product adoption, commercialization, and the ability to expand its testing platform across use cases. Investors usually watch device rollout, adoption, and revenue growth.
Position Within the Biotechnology Landscape
Intelligent Bio Solutions is part of the diagnostics and biosensor infrastructure layer. It is not biotech, but it is relevant to the broader testing ecosystem.
Future catalysts
Intelligent Bio Solutions’ catalysts are drug-testing and workplace-safety products, plus any commercial update that clarifies adoption. The story is about product utilization and recurring demand.
Recent news
- 01
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
Source: Intelligent Bio Solutions
- 02
- 03
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
Source: Intelligent Bio Solutions
- 04
- 05
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
Source: Intelligent Bio Solutions
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Intelligent Bio Solutions (INBS)?
Intelligent Bio Solutions (INBS) most recently closed at 1.99 USD, a +11.17% move versus the previous session.
What is the market cap of Intelligent Bio Solutions (INBS)?
Intelligent Bio Solutions currently has a market capitalization of 6.08M USD on BioPharmSignal.
What does Intelligent Bio Solutions do?
Intelligent Bio Solutions is a diagnostics company focused on rapid biosensor testing and point-of-care identification. Its business centers on using sensor technology to improve screening and clinical workflows.
On which exchange is INBS stock listed?
Intelligent Bio Solutions (INBS) is associated with NASDAQ, United States, MedTech.
What is Intelligent?
Intelligent Bio Solutions’ catalysts are drug-testing and workplace-safety products, plus any commercial update that clarifies adoption.
Which conditions is Intelligent Bio Solutions targeting with Intelligent?
Intelligent Bio Solutions’ catalysts are drug-testing and workplace-safety products, plus any commercial update that clarifies adoption.
How does Intelligent Bio Solutions describe recent progress with Intelligent?
Intelligent Bio Solutions’ catalysts are drug-testing and workplace-safety products, plus any commercial update that clarifies adoption.
What is Solutions?
Intelligent Bio Solutions is a diagnostics company focused on rapid biosensor testing and point-of-care identification.